United States - English - NLM (National Library of Medicine)

antigen laboratories, inc. - dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k) - dermatophagoides pteronyssinus 10000 [au] in 1 ml - indications and usage     standardized mite allergenic extract is indicated for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. an orderly approach to the diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing.     mite mixtures should not be used for diagnostic skin testing. the individual mites should be used. mite mixtures may be used for immunotherapy to treat patients who demonstrated sensi­tivity to both d. farinae and d. pteronyssinus mites. patients who react to both d. farinae and d. pteronyssinus have demonstrated a significant cross-reactivity. caution should be used in esca­lating treatment with mite mixtures.21 prick-puncture testing:

Canada - English - Health Canada

greer laboratories inc - dermatophagoides pteronyssinus - liquid - 5000unit - dermatophagoides pteronyssinus 5000unit - allergenic extracts

Canada - English - Health Canada

greer laboratories inc - dermatophagoides pteronyssinus - liquid - 10000unit - dermatophagoides pteronyssinus 10000unit - allergenic extracts

Canada - English - Health Canada

greer laboratories inc - dermatophagoides pteronyssinus - liquid - 30000unit - dermatophagoides pteronyssinus 30000unit - allergenic extracts

New Zealand - English - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 0.1 ir/ml (dermatophagoides pteronyssinus body extract); allergen extracts 1 ir/ml (dermatophagoides pteronyssinus body extract); allergen extracts 10 ir/ml (dermatophagoides pteronyssinus body extract) - solution for injection - active: allergen extracts 0.1 ir/ml (dermatophagoides pteronyssinus body extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ir/ml (dermatophagoides pteronyssinus body extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ir/ml (dermatophagoides pteronyssinus body extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

New Zealand - English - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ir/ml (dermatophagoides pteronyssinus body extract) - solution for injection - 10 ir/ml - active: allergen extracts 10 ir/ml (dermatophagoides pteronyssinus body extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alk-abello ltd - dermatophagoides pteronyssinus allergen extract - solution for skin-prick test

Canada - English - Health Canada

alk-abello inc - dermatophagoides pteronyssinus - liquid - 10000unit - dermatophagoides pteronyssinus 10000unit - allergenic extracts

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - european house dust mite extract, quantity: 6 sq-hdm; american house dust mite extract, quantity: 6 sq-hdm - tablet - excipient ingredients: gelatin; sodium hydroxide; purified water; mannitol - allergic rhinitis acarizax is indicated for the treatment of house dust mite (hdm) allergic rhinitis not well controlled despite use of symptom relieving medication in adults and adolescents (? 12 years). allergic asthma acarizax is indicated for the treatment of hdm allergic asthma not well controlled by inhaled corticosteroids and associated with hdm allergic rhinitis in adults. patients? asthma status should be carefully evaluated before the initiation of treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - american house dust mite extract, quantity: 5 ir/ml; european house dust mite extract, quantity: 5 ir/ml - injection, suspension - excipient ingredients: sodium chloride; phenol; water for injections; aluminium hydroxide hydrate; mannitol - treatment of patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.